Tolga Tanguler

Insider Reports History

Location
Cambridge, MA
Signature
By: Brett Budzinski, Attorney-in-Fact For: Tolga Tanguler
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Tolga Tanguler:

Company Role Class Num Shares Value Price $ Report Date Ownership
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Commercial Officer Common Stock 31,769 $9,850,956 $310.08 13 Feb 2026 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Commercial Officer Restricted Stock Units 1,666 $406,687 $244.11 27 Feb 2025 Direct
Lexeo Therapeutics, Inc. Director Stock Option (right to buy) 14,583 26 Jun 2025 Direct
ALNYLAM PHARMACEUTICALS, INC. EVP, Chief Commercial Officer Stock Option (right to buy) 7,819 03 Mar 2025 Direct

Insider Reports Filed by Tolga Tanguler

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ALNY ALNYLAM PHARMACEUTICALS, INC. 12 Feb 2026 2 -$607,448 4 EVP, Chief Commercial Officer 17 Feb 2026, 19:27
ALNY ALNYLAM PHARMACEUTICALS, INC. 11 Jan 2026 22 -$547,927 4 EVP, Chief Commercial Officer 14 Jan 2026, 16:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Oct 2025 13 -$635,126 4 EVP, Chief Commercial Officer 03 Oct 2025, 17:14
ALNY ALNYLAM PHARMACEUTICALS, INC. 29 Aug 2025 6 -$1,557,649 4 EVP, Chief Commercial Officer 02 Sep 2025, 16:10
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Aug 2025 9 -$632,759 4 EVP, Chief Commercial Officer 19 Aug 2025, 17:28
LXEO Lexeo Therapeutics, Inc. 26 Jun 2025 1 $0 4 Director 30 Jun 2025, 17:00
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Mar 2025 8 -$114,820 4 EVP, Chief Commercial Officer 05 Mar 2025, 16:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2025 10 -$123,983 4 EVP, Chief Commercial Officer 03 Mar 2025, 16:31
ALNY ALNYLAM PHARMACEUTICALS, INC. 25 Nov 2024 6 -$368,686 4 EVP, Chief Commercial Officer 27 Nov 2024, 17:21
LXEO Lexeo Therapeutics, Inc. 11 Nov 2024 1 $0 4 Director 13 Nov 2024, 17:34
LXEO Lexeo Therapeutics, Inc. 11 Nov 2024 0 $0 3 Director 13 Nov 2024, 17:31
ALNY ALNYLAM PHARMACEUTICALS, INC. 24 Jun 2024 13 -$370,747 4 EVP, Chief Commercial Officer 26 Jun 2024, 16:26
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Mar 2024 2 $0 4 EVP, Chief Commercial Officer 05 Mar 2024, 16:22
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2024 7 -$77,805 4 EVP, Chief Commercial Officer 29 Feb 2024, 16:18
ALNY ALNYLAM PHARMACEUTICALS, INC. 15 Feb 2024 4 -$149,397 4 EVP, Chief Commercial Officer 20 Feb 2024, 16:08
ALNY ALNYLAM PHARMACEUTICALS, INC. 26 Apr 2023 6 -$287,215 4 EVP, Chief Commercial Officer 28 Apr 2023, 17:55
ALNY ALNYLAM PHARMACEUTICALS, INC. 27 Feb 2023 2 $0 4 EVP, Chief Commercial Officer 01 Mar 2023, 15:21
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Feb 2023 11 -$1,156,692 4 EVP, Chief Commercial Officer 03 Feb 2023, 16:45
ALNY ALNYLAM PHARMACEUTICALS, INC. 03 Aug 2022 12 -$1,112,787 4 EVP, Chief Commercial Officer 05 Aug 2022, 16:15
ALNY ALNYLAM PHARMACEUTICALS, INC. 05 Jul 2022 1 -$263,100 4 EVP, Chief Commercial Officer 07 Jul 2022, 16:06
ALNY ALNYLAM PHARMACEUTICALS, INC. 23 Feb 2022 1 $0 4 EVP, Chief Commercial Officer 25 Feb 2022, 15:12
ALNY ALNYLAM PHARMACEUTICALS, INC. 01 Feb 2022 3 -$219,609 4 EVP, Chief Commercial Officer 03 Feb 2022, 15:10